CAM
ANAB icon

Cormorant Asset Management’s AnaptysBio ANAB Stock Holding History

Cormorant Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-342,465
Closed -$11.5M – 49
2024
Q3 		$11.5M Buy
+342,465
New +$11.7M 0.61% 35
2022
Q3 		– Sell
-50,000
Closed -$1.01M – 75
2022
Q2 		$1.01M Hold
50,000
– – 0.08% 72
2022
Q1 		$1.24M Sell
50,000
-50,000
-50% -$1.51M 0.1% 72
2021
Q4 		$3.48M Sell
100,000
-285,081
-74% -$9.04M 0.21% 62
2021
Q3 		$10.4M Hold
385,081
– – 0.42% 52
2021
Q2 		$9.98M Sell
385,081
-264,919
-41% -$6.35M 0.34% 62
2021
Q1 		$14M Hold
650,000
– – 0.31% 61
2020
Q4 		$14M Hold
650,000
– – 0.33% 58
2020
Q3 		$9.59M Sell
650,000
-235,838
-27% -$4.25M 0.37% 61
2020
Q2 		$19.8M Sell
885,838
-222,062
-20% -$4.06M 0.76% 43
2020
Q1 		$15.7M Buy
1,107,900
+742,900
+204% +$11.3M 0.73% 39
2019
Q4 		$5.93M Sell
365,000
-226,200
-38% -$5.35M 0.24% 58
2019
Q3 		$20.7M Sell
591,200
-108,800
-16% -$5.18M 1.26% 28
2019
Q2 		$39.5M Sell
700,000
-220,000
-24% -$15.8M 2.27% 14
2019
Q1 		$67.2M Sell
920,000
-185,557
-17% -$12.8M 4.54% 6
2018
Q4 		$70.5M Sell
1,105,557
-29,443
-3% -$2.19M 5.73% 3
2018
Q3 		$113M Sell
1,135,000
-98,422
-8% -$8.17M 7.36% 1
2018
Q2 		$87.6M Buy
1,233,422
+129,400
+12% +$10.9M 6.48% 4
2018
Q1 		$115M Sell
1,104,022
-147,463
-12% -$16.6M 8.57% 3
2017
Q4 		$126M Buy
1,251,485
+251,485
+25% +$18.5M 13.19% 1
2017
Q3 		$35M Buy
1,000,000
+200,531
+25% +$5.41M 6.17% 4
2017
Q2 		$19.1M Sell
799,469
-96,157
-11% -$2.42M 3.17% 10
2017
Q1 		$24.9M Buy
+895,626
New +$20.9M 3.61% 5

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Cormorant Asset Management's ANAB Position: Q4 2024 in Review

Cormorant Asset Management sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 342,465 shares — an estimated $11.5M sold.

Cormorant Asset Management first reported a position in ANAB in Q1 2017 and held it in 23 quarters. The position peaked at $126M in Q4 2017. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

  • Cormorant Asset Management reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
  • Cormorant Asset Management sold 342,465 AnaptysBio shares in Q4 2024, an estimated $11.5M.
  • Cormorant Asset Management first reported a position in AnaptysBio in Q1 2017 and held it in 23 quarters.
  • Cormorant Asset Management's AnaptysBio position peaked at $126M in Q4 2017.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Cormorant Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.